The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Cyclodextrin complexes: Perspective from drug delivery and formulation
Abstract
Cyclodextrins (CDs) have been widely investigated as a unique pharmaceutical excipient for past few decades and is still explored for new applications. They are highly versatile oligosaccharides which possess multifunctional characteristics, and are mainly used to improve the physicochemical stability, solubility, dissolution rate, and bioavailability of drugs. Stability constant, factors affecting complexation, techniques to enhance complexation efficiency, the preparation methods for molecular inclusion complexes and release of guest molecules are discussed in brief. In addition, different CD derivatives and their pharmacokinetics are elaborated. Further, the significance of CD complex in aqueous solubility, dissolution and bioavailability, stability, and taste masking is explained. The recent advancement of CDs in developing various drug delivery systems is enlightened. Indeed, the potential of CDs by means of inclusion complex formation have widen the applicability of these materials in various drug delivery systems including ocular, osmotic, mucoadhesive, transdermal, nasal, and targeted delivery systems. Feasibility studies have been performed on the benefit of these cyclic oligomers as nanocarriers, a strategy that can modify the drugs with improved physicochemical properties. Studies also demonstrated the feasibility of CDs to self‐assemble in the form of stable nanoaggregates, which may extend the scope of CDs in drug delivery to the continually expanding list of new drug entities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sun, L., Zhou, D., Zhang, P., Li, Q.-H., & Liu, P. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.052 · Cited by 25
RetractedCyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375
ENCYCLOPEDIA OF Surface and Colloid Science
Somasundaran, P., & Hubbard, A. T. (2021) · CRC Press eBooks · doi:10.1201/9780367813437 · Cited by 2,104
Stella, V. J., & He, Q. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310945 · Cited by 700
The utility of cyclodextrins for enhancing oral bioavailability
Carrier, R. L., Miller, L. A., & Ahmed, I. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.018 · Cited by 557
Connecting Soil Organic Carbon and Root Biomass with Land-Use and Vegetation in Temperate Grassland
McGranahan, D. A., Daigh, A. L., Veenstra, J. J., Engle, D. M., Miller, J. R., & Debinski, D. M. (2014) · The Scientific World Journal · doi:10.1155/2014/487563 · Cited by 493
Cyclodextrin-based gene delivery systems
Mellet, C. O., Fernández, J. M. G., & Benito, J. M. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00019a · Cited by 393
Jambhekar, S. S., & Breen, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.017 · Cited by 383
Loftsson, T., & Brewster, M. E. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01279.x · Cited by 286
Jambhekar, S. S., & Breen, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.016 · Cited by 197
Zhang, N., Li, J., Jiang, W., Ren, C., Li, J., Xin, J., & Li, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.006 · Cited by 189
Development of formulations that enhance physical stability of viral vectors for gene therapy
Croyle, M., Cheng, X., & Wilson, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301527 · Cited by 188
Liposomes incorporating cyclodextrin–drug inclusion complexes: Current state of knowledge
Gharib, R., Greige-Gerges, H., Fourmentin, S., Charcosset, C., & Auezova, L. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.04.048 · Cited by 176
8. Advances in analytical chemistry and instrumentation
(1966) · Vacuum · doi:10.1016/0042-207x(66)92527-9 · Cited by 175
Cyclodextrins: application in different routes of drug administration.
Shimpi, S., Chauhan, B., & Shimpi, P. C. (2005) · PubMed · Cited by 173
Amphiphilic Cyclodextrins – Advances in Synthesis and Supramolecular Chemistry
Sallas, F., & Darcy, R. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200700933 · Cited by 172
Cyclodextrin nanosystems in oral drug delivery: A mini review
Adeoye, O., & Cabral-Marques, H. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.050 · Cited by 159
Bhatt, P., Lalani, R., Vhora, I., Patil, S., Amrutiya, J., Misra, A., & Mashru, R. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.048 · Cited by 159
Agüeros, M., Zabaleta, V., Espuelas, S., Campanero, M. A., & Irache, J. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.012 · Cited by 156
Cyclodextrin-Mediated Enhancement of Riboflavin Solubility and Corneal Permeability
Morrison, P. W. J., Connon, C. J., & Khutoryanskiy, V. V. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005963 · Cited by 153
Colonic Drug Delivery: Prodrug Approach
Sinha, V. R., & Kumria, R. (2001) · Pharmaceutical Research · doi:10.1023/a:1011033121528 · Cited by 149
Prabaharan, M., & Gong, S. (2007) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2007.11.005 · Cited by 148
Bilensoy, E., Rouf, M. A., Vural, İ., Şen, M., & Hıncal, A. A. (2006) · AAPS PharmSciTech · doi:10.1208/pt070238 · Cited by 146
Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine
Luppi, B., Bigucci, F., Corace, G., Delucca, A., Cerchiara, T., Sorrenti, M., Catenacci, L., Pietra, A. M. D., & Zecchi, V. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.002 · Cited by 143
Zhang, P., Liu, X., Hu, W., Bai, Y., & Zhang, L. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.04.115 · Cited by 138
de Araújo, D. R., Tsuneda, S. S., Cereda, C. M. S., Carvalho, F. D. G. F., Preté, P. S. C., Fernandes, S. A., Yokaichiya, F., Franco, M. K. K. D., Mazzaro, I., Fraceto, L. F., et al. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.09.010 · Cited by 136
Fast releasing oral electrospun PVP/CD nanofiber mats of taste-masked meloxicam
Samprasit, W., Akkaramongkolporn, P., Ngawhirunpat, T., Rojanarata, T., Kaomongkolgit, R., & Opanasopit, P. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.044 · Cited by 133
Godinho, B. M. D. C., Ogier, J. R., Darcy, R., O’Driscoll, C. M., & Cryan, J. F. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3003946 · Cited by 126
Coisne, C., Tilloy, S., Monflier, É., Wils, D., Fénart, L., & Gosselet, F. (2016) · Molecules · doi:10.3390/molecules21121748 · Cited by 125
Corti, G., Cirri, M., Maestrelli, F., Mennini, N., & Mura, P. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.06.004 · Cited by 116
Cyclodextrin nanoassemblies: a promising tool for drug delivery
Bonnet, V., Gervaise, C., Djedaïni‐Pilard, F., Furlan, A. L., & Sarazin, C. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.008 · Cited by 113
Gioia, S. D., Trapani, A., Mandracchia, D., Giglio, E. D., Cometa, S., Mangini, V., Arnesano, F., Belgiovine, G., Castellani, S., Pace, L., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.019 · Cited by 110
Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability
Siemoneit, U., Schmitt, C., Alvarez‐Lorenzo, C., et al. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.046 · Cited by 104
New Supramolecular Assemblies of a Cyclodextrin-Grafted Chitosan through Specific Complexation
Auzély‐Velty, R., & Rinaudo, M. (2002) · Macromolecules · doi:10.1021/ma020664o · Cited by 103
Arima, H., Yoshimatsu, A., Ikeda, H., Ohyama, A., Motoyama, K., Higashi, T., Tsuchiya, A., Niidome, T., Katayama, Y., Hattori, K., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300188f · Cited by 93
Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin
Nair, A. B., Attimarad, M., Al‐Dhubiab, B. E., Wadhwa, J., Sreeharsha, N., & Ahmed, K. M. (2013) · Drug Delivery · doi:10.3109/10717544.2013.853213 · Cited by 93
Self-citationβ-Cyclodextrin hydrogels for the ocular release of antibacterial thiosemicarbazones
Glisoni, R. J., Garcia‐Fernandez, M. J., Pino, M., Gutkind, G., Moglioni, A. G., Alvarez‐Lorenzo, C., Concheiro, Á., & Sosnik, A. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.12.033 · Cited by 90
Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir
Al‐Dhubiab, B. E., Nair, A. B., Kumria, R., Attimarad, M., & Sreeharsha, N. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.10.045 · Cited by 87
Self-citationTopical drug delivery to the eye: dorzolamide
Loftsson, Þ., Jansook, P., & Stefánsson, E. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02299.x · Cited by 87
Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan
Trapani, A., García-Fuentes, M., & Alonso, M. J. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/18/185101 · Cited by 86
Lopez, R. F. V., Collett, J. H., & Bentley, M. V. L. B. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00365-3 · Cited by 85
Alomrani, A. H., Shazly, G. A., Amara, A. A., & Badran, M. M. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.05.030 · Cited by 79
Bilensoy, E., Çırpanlı, Y., Şen, M., et al. (2007) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-006-9259-y · Cited by 77
Practical considerations in development of solid dosage forms that contain cyclodextrin
Miller, L. A., Carrier, R. L., & Ahmed, I. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20831 · Cited by 77
Cyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro Studies
Yang, T., Hussain, A., Paulson, J. R., Abbruscato, T. J., & Ahsan, F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032998.84488.7a · Cited by 77
Cevher, E., Açma, A., Sinani, G., Aksu, B., Zloh, M., & Mülazımoğlu, L. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.05.033 · Cited by 72
Vega, E., Egea, M. A., Garduño-Ramírez, M. L., García, M. L., Sánchez‐López, E., Espina, M., & Calpena, A. C. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.04.045 · Cited by 71
Wang, F., Bao, X., Fang, A., Li, H., Zhou, Y., Liu, Y., Jiang, C., Wu, J., & Song, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00091 · Cited by 71
Bioadhesive properties and biodistribution of cyclodextrin–poly(anhydride) nanoparticles
Agüeros, M., Areses, P., Campanero, M. Á., Salman, H. H., Quincoces, G., Peñuelas, I., & Irache, J. M. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.010 · Cited by 67
A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery
Ye, Y., Sun, Y., Zhao, H., Lan, M., Gao, F., Song, C., Lou, K., Li, H., & Wang, W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.10.005 · Cited by 66
Sherje, A. P., & Londhe, V. Y. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0844-8 · Cited by 65
Ventura, C. A., Tommasini, S., Falcone, A., Giannone, I., Paolino, D., Sdrafkakis, V., Mondello, M., & Puglisi, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.006 · Cited by 63
Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation
Zainuddin, R., Zaheer, Z., Sangshetti, J. N., & Momin, M. M. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1371732 · Cited by 63
Preparation and Evaluation of Gastroretentive Floating Tablets of Silymarin
Garg, R., & Gupta, G. D. (2009) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.57.545 · Cited by 62
Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs.
Loftsson, Þ., Sigurðsson, H. H., Másson, M., & Schipper, N. G. M. (2004) · PubMed · Cited by 57
Mura, P., Bragagni, M., Mennini, N., Cirri, M., & Maestrelli, F. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.066 · Cited by 56
Drug-Cyclodextrin-Vesicles Dual Carrier Approach for Skin Targeting of Anti-acne Agent
Kaur, N., Puri, R., & Jain, S. K. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9411-2 · Cited by 55
Nagai, N., Yoshioka, C., Mano, Y., Tnabe, W., Ito, Y., Okamoto, N., & Shimomura, Y. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.01.022 · Cited by 54
Phan, C., Subbaraman, L. N., & Jones, L. (2014) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2014.958016 · Cited by 54
Ünal, H., Öztürk, N., & Bilensoy, E. (2015) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.11.22 · Cited by 52
Preparation and Evaluation of Fast-Disintegrating Effervescent Tablets of Glibenclamide
Jacob, S., Shirwaikar, A., & Nair, A. B. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802337021 · Cited by 51
Self-citationFiorica, C., Palumbo, F. S., Pitarresi, G. L., Bongiovì, F., & Giammona, G. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.02.071 · Cited by 48
Zhang, L., Lu, J., Jin, Y., & Qiu, L. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.07.005 · Cited by 47
Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery
Varan, G., Benito, J. M., Mellet, C. O., & Bilensoy, E. (2017) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.8.145 · Cited by 47
Mucoadhesive microspheres for nasal administration of cyclodextrins
Gavini, E., Rassu, G., Haukvik, T., Lanni, C., Racchi, M., & Giunchedi, P. (2008) · Journal of drug targeting · doi:10.1080/10611860802556842 · Cited by 46
Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach
Ascenso, A., Cruz, M., Euletério, C., Carvalho, F. A., Santos, N. C., Cabral-Marques, H. M., & Simões, S. (2013) · Journal of Liposome Research · doi:10.3109/08982104.2013.788026 · Cited by 46
Li, P., Wang, S., Chen, H., Zhang, S., Yu, S., Li, Y., Cui, M., Pan, W., & Yang, X. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1414232 · Cited by 45
α-Cyclodextrin/oil beads: An innovative self-assembling system
Bochot, A., Trichard, L., Bas, G. L., Pinto‐Alphandary, H., Grossiord, J., Duchêne, D., & Fattal, E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.034 · Cited by 38
Diniz, T. C., Pinto, T. C. C., Menezes, P. D. P., Silva, J. C., Teles, R. B. D. A., Ximenes, R. C. C., Guimarães, A. G., Serafini, M. R., Araújo, A. A. D. S., Quintans‐Júnior, L. J., et al. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1384816 · Cited by 38
Yalcin, A., Soddu, E., Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Armagan, G., Rassu, G., Gavini, E., & Giunchedi, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.05.017 · Cited by 37
Jóhannsdóttir, S., Kristinsson, J. K., Fülöp, Z., Ásgrímsdóttir, G. M., Stefánsson, E., & Loftsson, Þ. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.044 · Cited by 37
Kulkarni, J. A., & Avachat, A. M. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1236808 · Cited by 35
Late, S., & Banga, A. K. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9541-6 · Cited by 34
Nicolazzi, C., Venard, V., Faou, A. L., & Finance, C. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00218-2 · Cited by 33
Chen, Y., Huang, Y., Qin, D., Liu, W., Song, C., Lou, K., Wang, W., & Gao, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150877 · Cited by 31
Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins
El-Gawad, A. E.-G. H. A., Soliman, O. A. E.-A., El-Dahan, M. S., & Al-Zuhairy, S. A. S. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0609-9 · Cited by 31
Yan, Y., Xing, J., Xu, W. L., Zhao, G., Dong, K., Zhang, L., & Wang, K. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.021 · Cited by 29
Muankaew, C., Jansook, P., Sigurðsson, H. H., & Loftsson, Þ. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.071 · Cited by 29
Spada, G., Gavini, E., Cossu, M., Rassu, G., & Giunchedi, P. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/9/095101 · Cited by 27
Carboxymethyl Dextran-Cyclodextrin Conjugate as the Carrier of Doxorubicin
Sivasubramanian, M., Thambi, T., Deepagan, V. G., et al. (2013) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2013.8091 · Cited by 27
Formulation of risperidone in floating microparticles to alleviate its extrapyramidal side effects
Ammar, H. O., Ghorab, M. M., Mahmoud, A. A. K., & Noshi, S. H. (2016) · Future Journal of Pharmaceutical Sciences · doi:10.1016/j.fjps.2016.08.001 · Cited by 26
Guo, Z., Wu, F., Singh, V., Guo, T., Ren, X., Yin, X., Shao, Q., York, P., Patterson, L. H., & Zhang, J. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.03.042 · Cited by 26
Bozkır, A., Denli, Z. F., & Başaran, B. (2012) · PubMed · Cited by 22
Blanchard, J., Ugwu, S. O., Bhardwaj, R., & Dorr, R. T. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100100548 · Cited by 20
Lu, S., Tao, E., Meng, Q., Hou, W., Liu, K., Shang, H., Tang, J., & Zhang, W. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s97982 · Cited by 20
Influence of β - cyclodextrin complexation on lovastatin release from osmotic pump tablets (OPT)
Mehramizi, A., Monfared, E. A., Bayati, K., Tehrani, M. R., Pourfarzib, M., & Dorkoush, F. (2007) · DARU Journal of Pharmaceutical Sciences · Cited by 19
Cyclodextrins and their Derivatives in Drug Delivery: A Review
Palem, C. R., Chopparapu, K. S. C., Subrahmanyam, P. V. R. S., & Yamsani, M. R. (2012) · Current Trends in Biotechnology and Pharmacy · Cited by 19
Buchwald, P., & Bodor, N. S. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.04.007 · Cited by 19
Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches
Obaidat, R., Al‐Shar’i, N. A., Tashtoush, B. M., & Athamneh, T. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1245319 · Cited by 19
Investigation of interaction of promethazine with cyclodextrins.
Lutka, A. (2002) · PubMed · Cited by 17
Nagase, Y., Arima, H., Wada, K., Sugawara, T., Satoh, H., Hirayama, F., & Uekama, K. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10517 · Cited by 17
Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone
Mennini, N., Casella, G., Cirri, M., Maestrelli, F., & Mura, P. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12549 · Cited by 17
The stability and dissolution properties of solid glucagon/γ-cyclodextrin powder
Matilainen, L., Maunu, S. L., Pajander, J. P., Auriola, S. O. K., Jääskeläinen, I., Larsen, K. L., Järvinen, T., & Jarho, P. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.11.006 · Cited by 13
Calles, J. A., Mora, M. J., Onnainty, R., Tártara, L. I., Granero, G. E., Longhi, M. R., Diebold, Y., Vallés, E. M., & Palma, S. D. (2018) · Therapeutic Delivery · doi:10.4155/tde-2017-0087 · Cited by 13
Ganapathy, H. S., Lee, M. Y., Park, C., & Lim, K. T. (2008) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2008.09.005 · Cited by 11
Diclofenac-β-cyclodextrin for colonic drug targeting: In vivo performance in rats
Vieira, A. C. F., Serra, A. C., Veiga, F., Gonsalves, A. M. D. R., Basit, A. W., & Murdan, S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.024 · Cited by 11
Drug delivery strategies for common orofacial diseases
Liu, X.-M., Reinhardt, R. A., & Wang, D. (2006) · Journal of drug targeting · doi:10.1080/10611860600834433 · Cited by 7
Gastro-retentive floating beads of curcumin β-cyclodextrin complex to treat stomach tumors
Goindi, S., Mann, K., & Aggarwal, N. (2011) · Alternative Medicine Studies · doi:10.4081/ams.2011.e12 · Cited by 7
Cited by
Metal-organic frameworks for stimuli-responsive drug delivery
Wang, Y., Yan, J., Wen, N., Xiong, H., Cai, S., He, Q., Hu, Y., Peng, D., Liu, Z., & Liu, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119619 · Cited by 665
Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management
Jacob, S., Nair, A. B., Shah, J., Sreeharsha, N., Gupta, S., & Shinu, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030357 · Cited by 485
Self-citationEmerging role of nanosuspensions in drug delivery systems
Jacob, S., Nair, A. B., & Shah, J. (2020) · Biomaterials Research · doi:10.1186/s40824-020-0184-8 · Cited by 415
Self-citationRole of Drug Delivery System in Improving the Bioavailability of Resveratrol
Saleem, Z., Rehman, K., & Hamid Akash, M. S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220705113514 · Cited by 34
Metadata
- Authors
- Jacob, S., & Nair, A. B.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 2018-08
- Volume
- 79
- Issue
- 5
- Pages
- 201-217
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W2891842676
- Cited by
- 260
- References
- 98
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.